Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time

A diagnosis of bladder cancer can be scary. But many people can be cured, thanks to early detection. The bladder cancer survival rate changes a lot based on when it’s found.

Bladder Cancer Survival Rate: Positive Cure Facts
Bladder Cancer Survival Rate: Positive Cure Facts 4

The American Cancer Society says the 5-year survival rate for bladder cancer is key. Early finds and new treatments have made things better for many. Can bladder cancer be completely cured? Check the bladder cancer survival rate. Positive, powerful facts about cure and long-term remission, especially at early stages.

Key Takeaways

  • Early detection significantly improves the bladder cancer survival rate.
  • Advancements in medical treatments offer new hope for patients.
  • The stage at diagnosis is a critical factor in bladder cancer prognosis.
  • Many people can be cured if the cancer is detected early.
  • Understanding the factors that influence survival rate is important for patients and their families.

5 Key Facts About Bladder Cancer Curability

To figure out if bladder cancer is curable, we need to look at several important points. We must understand how different factors affect treatment success and patient outcomes.

What Defines a “Cure” for Bladder Cancer

The National Cancer Institute says a “cure” means all cancer is gone and won’t come back. For bladder cancer, this means the cancer is treated and doesn’t return. But the idea of a “cure” is complex. It depends on the cancer’s stage and type at the start.

Early detection is key to a cure. Finding bladder cancer early means treatments work better. This raises the chances of a good outcome.

Types of Bladder Cancer and Their Curability Rates

Bladder cancer types have different cure rates. Non-muscle-invasive bladder cancer is more curable than muscle-invasive or metastatic types. New treatments, like TAR-200, offer hope for BCG-unresponsive cases.

  • Non-muscle-invasive bladder cancer:enerally has a higher curability rate.
  • Muscle-invasive bladder cancer: Requires more aggressive treatment and has a lower curability rate.
  • Metastatic bladder cancer: Hs a poorer prognosis but can be managed with appropriate treatment.
Bladder Cancer Survival Rate: Positive Cure Facts
Bladder Cancer Survival Rate: Positive Cure Facts 5

The Importance of Early Detection

Early detection is vital for bladder cancer treatment. Early-stage cancer is more treatable. Regular check-ups and knowing risk factors help catch cancer early.

In summary, bladder cancer curability depends on the cancer type and stage, and early detection. By looking at these factors, we can understand the cure chances and the best treatments.

Bladder Cancer Survival Rate: The Complete Picture

The survival rate for bladder cancer changes a lot based on when it’s found. Knowing these numbers helps patients, their families, and doctors make better choices about treatment.

Bladder Cancer Survival Rate: Positive Cure Facts
Bladder Cancer Survival Rate: Positive Cure Facts 6

The 79% Overall 5-Year Survival Rate in the US

In the US, the 5-year survival rate for bladder cancer is 79%. This number comes from patients diagnosed between 2011 and 2017, as reported by the Surveillance, Epidemiology, and End Results (SEER) database. It’s important to remember that survival rates can change based on many things, like the cancer’s stage.

Localized bladder cancer, where the cancer stays in the bladder, has a 5-year survival rate of 71%. On the other hand, metastatic bladder cancer, where the cancer spreads, has a much lower rate of 8% Source.

Early-Stage Bladder Cancer: The 97.9% Survival Rate

For those with early-stage bladder cancer, the outlook is good. The 5-year survival rate for this group is 97.9%. This shows that almost all patients diagnosed early can live for at least five years after finding out. Early detection and treatment are key to this high survival rate.

“Early detection of bladder cancer significantly improves the chances of survival. Regular check-ups and awareness of the symptoms can lead to earlier diagnosis and more effective treatment.”-Research shows.

Metastatic Bladder Cancer: Understanding the 9.1% Survival Rate

On the other hand, metastatic bladder cancer has a much worse outlook. The 5-year survival rate for this advanced stage is 9.1%. Patients and doctors need to understand challenges and treatment options at this stage.

Survival Rates by Age and Gender

Survival rates for bladder cancer also change with age and gender. Younger patients usually have better survival rates than older ones. Studies show that women might have a slightly higher 5-year survival rate for bladder cancer than men, but this depends on many factors.

As we learn more about bladder cancer, it’s vital to look at these statistics in the context of each patient’s situation. Survival rates are just one part of the picture. Personal health, how well someone responds to treatment, and other factors also play big roles in outcomes.

4 Critical Factors That Determine Bladder Cancer Curability

The chance of beating bladder cancer depends on several key factors. These factors affect how well treatment works and how long a patient might live. At Liv Hospital, we’re known worldwide for our top-notch care. We use the latest treatments and focus on making sure our patients get the best care possible.

Cancer Stage and Grade at Diagnosis

The stage and grade of bladder cancer at diagnosis are very important. Early-stage bladder cancer has a much better chance of being cured than later stages. The Canadian Cancer Society says knowing the stage and grade helps doctors plan the best treatment.

  • The stage of cancer shows how far it has spread.
  • The grade of cancer tells us how abnormal the cancer cells are.
  • Both stage and grade are key in figuring out the prognosis and treatment.

Patient-Specific Factors: Age, Health, and Comorbidities

Age, health, and other health issues also matter a lot. Older patients or those with health problems might face more challenges than younger, healthier people. We take these factors into account when making treatment plans for each patient.

  1. Age can affect how well a patient can handle certain treatments.
  2. Overall health is important for how well a patient can recover.
  3. Comorbidities can make treatment harder and affect the patient’s outlook.

Treatment Response and Recurrence Patterns

How a patient reacts to treatment and how often the cancer comes back are also important. Watching how a patient responds and how often the cancer comes back helps us change treatment plans if needed. This can help improve the patient’s chances of doing well.

It’s vital to understand these factors to find the best treatment. This can help patients with bladder cancer have a better chance of a successful outcome.

Treatment Options and Their Success Rates

Bladder cancer treatment now includes many therapies, helping patients more. It’s key to know how well each treatment works.

Non-Muscle Invasive Bladder Cancer Treatments

For non-muscle-invasive bladder cancer, treatments are less invasive. Transurethral resection of bladder tumor (TURBT) is a common procedure. It’s often followed by intravesical therapy to stop cancer from coming back.

Intravesical therapy delivers medicine directly into the bladder. This helps prevent cancer from returning. Success rates for these treatments are high, thanks to early detection.

Muscle-Invasive and Advanced Bladder Cancer Approaches

Muscle-invasive and advanced bladder cancer needs stronger treatments. Radical cystectomy, or removing the bladder, is often needed. This might be followed by chemotherapy or radiation therapy to kill all cancer cells.

The success of these treatments depends on several factors. These include the cancer’s stage and the patient’s health. Knowing these factors helps choose the best treatment.

Breakthrough Therapies Changing the Landscape

New treatments like immunotherapy and targeted therapy are changing bladder cancer treatment. These breakthroughs offer hope, mainly for those with advanced cancer.

Immunotherapy boosts the body’s immune system to fight cancer better. Targeted therapy attacks specific cancer cell traits. These therapies are expanding treatment options and improving results.

Life After Bladder Removal: Quality of Life Considerations

Life after bladder removal is a big change. It’s important to understand what living without a bladder means. This helps manage expectations and improve quality of life.

Patients can have a good life after bladder removal. There are many ways to manage urine. Working with healthcare providers is key to finding the right solution.

With about 84,870 new bladder cancer cases expected in 2025, knowing about treatments is vital. As treatments get better, patients have more hope for managing and beating the disease.

Conclusion: The Evolving Future of Bladder Cancer Treatment

Bladder cancer treatment is changing fast. New surgical methods, intravesical therapies, and immunotherapy are making a big difference. At Liv Hospital, we’re always updating our treatments to give our patients the best care.

Can bladder cancer be cured? It depends on the cancer’s stage and grade when it’s found. Early detection and the right treatment can lead to good outcomes. We’re working hard to keep up with new medical discoveries to help those with bladder cancer.

We’re excited about the future of bladder cancer care. With advanced treatments and a focus on our patients, we’re hopeful for better results. Our goal is to provide top-notch healthcare and keep improving how we treat this disease.

FAQ

Is bladder cancer curable?

Yes, many people can be cured of bladder cancer if caught early. The chance of being cured depends on several things. These include the cancer’s stage and type, and the patient’s health.

What is the survival rate for bladder cancer?

In the US, the 5-year survival rate for bladder cancer is 79%. Bu, this rate changes a lot based on when the cancer is found. Early-stage cancer has a 97.9% survival rate. Metastatic cancer has a 9.1% rate.

How does the stage of bladder cancer affect the survival rate?

The stage of bladder cancer is very important for survival rates. Early-stage cancer has a much better rate than metastatic cancer.

What are the treatment options for bladder cancer?

Treatment for bladder cancer depends on its stage and type, and the patient’s health. Options include TURBT, intravesical therapy, radical cystectomy, chemotherapy, and immunotherapy.

Can you live without a bladder?

Yes, living without a bladder is possible. But it means big lifestyle changes and ongoing medical care to manage the changes.

What is the life expectancy after bladder removal?

Life expectancy after bladder removal varies. It depends on the patient’s health, cancer stage, and any other health issues.

How does age affect bladder cancer survival rates?

Age can affect survival rates for bladder cancer. Older patients often have poorer outcomes because of other health issues and weaker health.

What is the prognosis for metastatic bladder cancer?

Metastatic bladder cancer has a poor prognosis, with a 9.1% 5-year survival rate. But, treatments like chemotherapy and immunotherapy can help manage the disease and improve life quality.

How does the type of bladder cancer affect curability?

The type of bladder cancer, like non-muscle-invasive or muscle-invasive, affects its curability. Non-muscle-invasive cancer is generally more curable than muscle-invasive or metastatic cases.


References

  1. National Cancer Institute. (2025). SEER cancer stat facts: Bladder cancer.https://seer.cancer.gov/statfacts/html/urinb.html
  2. American Cancer Society. (2025). Key statistics for bladder cancer.https://www.cancer.org/cancer/types/bladder-cancer/about/key-statistics.html
  3. Cancer Research UK. (2025). Survival of bladder cancer.https://www.cancerresearchuk.org/about-cancer/bladder-cancer/survival
i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 01